Latest statistics and disclosures from Ulys's latest quarterly 13F-HR filing:

  • As of June 30, 2016, Ulys has $62.01M in assets under management (AUM). Assets under management grew from a total value of $0 to $62.01M.
  • Independent of market fluctuations, Ulys was a net seller by $0 worth of stocks in the most recent quarter.

Ulys portfolio companies for June 2016 quarter

Company (Ticker) Portfolio Weight Share Count Price Last Trade
Lexicon Pharmaceuticals 100.00 4.32M 14.35 0.00
Ceres 0.00 3891 0.51 0.00

Past 13F-HR SEC Filings for Ulys

View All Filings